MedPath

Epinephrine

Generic Name
Epinephrine
Brand Names
Adrenalin, Allerject, Anapen, Articadent, Astracaine, Auvi-Q, Citanest, Citanest Forte, Emerade, Epipen, Lignospan, Marcaine, Marcaine With Epinephrine, Octocaine, Octocaine With Epinephrine, Orabloc, Scandonest, Sensorcaine, Sensorcaine With Epinephrine, Septanest, Septocaine, Symjepi, Ultacan, Ultracaine, Vivacaine, Xylocaine, Xylocaine With Epinephrine, Zorcaine, Eurneffy
Drug Type
Small Molecule
Chemical Formula
C9H13NO3
CAS Number
51-43-4
Unique Ingredient Identifier
YKH834O4BH

Overview

Epinephrine, also known as adrenaline, is a hormone and neurotransmitter and produced by the adrenal glands that can also be used as a drug due to its various important functions. Though it has long been used in the treatment of hypersensitivity reactions, epinephrine in the auto-injector form (EpiPen) has been available since 1987 in the USA. Many new products/biosimilars and dosage routes have been approved under various names over the last several decades , , . On August 16, 2018, Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths . Dosage delivery routes for epinephrine include intravenous, inhalation, nebulization, intramuscular injection, and subcutaneous injection. In general, the most common uses of parenteral epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity (anaphylactic or anaphylactoid) reactions to drugs, animal serums and other allergens, and to prolong the action of infiltration anesthetics . In addition to the above functions, epinephrine is the primary drug administered during cardiopulmonary resuscitation (CPR) to reverse cardiac arrest , . It can be used in severe cases of croup .

Background

Epinephrine, also known as adrenaline, is a hormone and neurotransmitter and produced by the adrenal glands that can also be used as a drug due to its various important functions. Though it has long been used in the treatment of hypersensitivity reactions, epinephrine in the auto-injector form (EpiPen) has been available since 1987 in the USA. Many new products/biosimilars and dosage routes have been approved under various names over the last several decades , , . On August 16, 2018, Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths . Dosage delivery routes for epinephrine include intravenous, inhalation, nebulization, intramuscular injection, and subcutaneous injection. In general, the most common uses of parenteral epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity (anaphylactic or anaphylactoid) reactions to drugs, animal serums and other allergens, and to prolong the action of infiltration anesthetics . In addition to the above functions, epinephrine is the primary drug administered during cardiopulmonary resuscitation (CPR) to reverse cardiac arrest , . It can be used in severe cases of croup .

Indication

Epinephrine injection is indicated in the emergency treatment of type I allergic reactions, including anaphylaxis. It is also used to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. Epinephrine's cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes but is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock . Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine injection can be utilized to prolong the action of local anesthetics . In addition to the above, epinephrine is used as an over the counter (OTC) agent for the intermittent symptoms of asthma, such as wheezing, tightness of chest and shortness of breath . It is also used for the maintenance of mydriasis during intraocular surgery .

Associated Conditions

  • Anaphylaxis
  • Angioneurotic Edema
  • Bleeding
  • Bronchospasm
  • Complete Heart Block
  • Hypotension
  • Idiopathic Anaphylaxis
  • Laryngotracheobronchitis
  • Mild Intermittent Asthma
  • Nasal Congestion
  • Open Angle Glaucoma (OAG)
  • Respiratory Distress
  • Severe Asthma
  • Syncope
  • Type I Hypersensitivity
  • Urticaria
  • Uterine Contractions
  • Ventricular Fibrillation
  • Resuscitation in cardiac arrest following anesthetic accidents
  • Severe hypersensitivity reactions
  • Unresponsive Asystole
  • Unresponsive Bradycardia

FDA Approved Products

Lidocaine
Manufacturer:CareStream Health, Inc.
Route:SUBCUTANEOUS
Strength:0.02 mg in 1 mL
Approved: 2017/12/21
NDC:31382-262
Epinephrine
Manufacturer:A-S Medication Solutions
Route:INTRAVENOUS
Strength:1 mg in 1 mL
Approved: 2023/10/05
NDC:50090-3039
ARTICAINE
Manufacturer:Benco Dental
Route:SUBMUCOSAL
Strength:0.005 mg in 1 mL
Approved: 2024/03/01
NDC:66975-418
EPIPEN JR
Manufacturer:Mylan Specialty L.P.
Route:INTRAMUSCULAR
Strength:0.15 mg in 0.3 mL
Approved: 2020/12/29
NDC:49502-501
Lidocaine
Manufacturer:Patterson Dental
Route:SUBMUCOSAL
Strength:0.02 mg in 1 mL
Approved: 2024/02/05
NDC:50227-1020

Singapore Approved Products

EpiPen (Epinephrine) Auto-Injector 0.3mg/dose (1mg/ml)
Manufacturer:Meridian Medical Technologies, Inc.
Form:INJECTION
Strength:1 mg/ml
Online:Yes
Approved: 2007/06/07
Approval:SIN13288P
ADRENALINE INJECTION 1:1000
Manufacturer:ATLANTIC LABORATORIES CORPN LTD
Form:INJECTION
Strength:1 mg/ml
Online:Yes
Approved: 1998/09/21
Approval:SIN10017P
ARTINIBSA 4% WITH EPINEPHRINE SOLUTION FOR INJECTION 1:100000
Manufacturer:Laboratorios Inibsa, S.A.
Form:INJECTION, SOLUTION
Strength:0.01mg
Online:Yes
Approved: 2020/03/18
Approval:SIN15913P
SURGICAINE Injection
Manufacturer:Novocol Pharmaceutical of Canada, Inc.
Form:INJECTION
Strength:0.005 mg
Online:Yes
Approved: 2012/11/22
Approval:SIN14273P
XILONIBSA Solution for Injection 2% 1:80000
Manufacturer:Laboratorios Inibsa, S.A.
Form:INJECTION, SOLUTION
Strength:0.0125mg/ml
Online:Yes
Approved: 2012/06/11
Approval:SIN14157P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath